With FDA Questions Answered, Edwards Expects Sapien Approval “Any Day”
This article was originally published in The Gray Sheet
Executive Summary
Edwards Lifesciences expects FDA approval of its Sapien transcatheter aortic heart valve replacement “any day,” CEO Michael Mussallem said Oct. 19.